2,136
Participants
Start Date
January 31, 2002
Primary Completion Date
November 30, 2015
Study Completion Date
November 30, 2015
CABG surgery plus MED
CABG plus standard medication management for Coronary Artery Disease
Active Medication Alone
Standard medication for coronary artery disease and heart failure management.
CABG plus MED and SVR
H02: the experimental arm receives active medical therapy and CABG and surgical ventricular restoration whereas the control group receives active medical therapy and CABG; for H01: the experimental arm receives active medical therapy and CABG whereas the control group receives active medical therapy alone
Duke University Medical Center, Durham
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Duke University
OTHER